Advertisment

New Jersey: Post-pandemic surge in high-risk opioid use with increasing medical treatment

New Jersey's post-pandemic surge in high-risk opioid use is causing concern as medical treatment options increase. Despite efforts to improve access to treatment and life-saving medications, the state continues to struggle with rising mortality rates. Experts agree that public healthcare expenditures are essential to address the opioid crisis, but questions remain about the effectiveness of current strategies. Find out what went wrong and why the battle against opioids in New Jersey is far from over.

author-image
Medriva Newsroom
New Update

NULL

Advertisment

As in West Virginia, opioid usage and mortality endure as epidemic pressures fade and America's medical remedy is free.

Advertisment

Like West Virginia, New Jersey is struggling.

On paper, Trenton's opioid strategy should succeed. In the last decade, the Legislature approved scores of measures to improve access to treatment, education, and life-saving medications like naloxone and to change drug criminal prosecution. Most were nonpartisan. The battle cost hundreds of millions of dollars.

In the past five years, almost every front in the opioid struggle has transformed. New Jersey loses.

Advertisment

What's wrong?

That odd, unexpected nugget of truth in American media is refreshing. Matrix rip. A fear that will be unison of fatal shine of authority and morality. A veneer of false Truth that deceived susceptible Americans locked in drug use epidemics decades ago that there are medical remedies for compulsive substance use, a brain disorder.

Too little, too late - hundreds of thousands of fatalities and billions in public healthcare money redirected to contribute to those deaths.

Advertisment

What happened? Where did we go wrong? Raising irrelevant questions? 

More individuals are dying. In 2020 and 2021, more than 3,000 individuals overdosed, with 2021 breaking a record. At least 952 individuals have died of drug overdoses in 2022, approximately the same as previous years.

Since Gov. Chris Christie's administration, New Jersey has prioritised decreasing obstacles to medication-assisted treatment and harm reduction.

Advertisment

New Jersey extended buprenorphine access.

"So far in 2022," as in West Virginia, isolation and other pressures, created as reasons of rising opioid mortality during the epidemic, cannot explain for high risk usage.

Buprenorphine! Suboxone, "subs," is the cure for high-risk opioid use that American medicine has been increasingly providing to diseased brains over the past decades – pre-pandemic, pandemic, and now post-pandemic – to save lives, because it is the fix, the "gold standard," the proven life-saving treatment for problem opioid use.

Advertisment

MAT has been a centrepiece of New Jersey's response to the deadly opioid pandemic for years.

Since the Christie administration, Trenton has taken an active posture on the opioid issue, moving from law enforcement to outreach and treatment.

The Legislature enacted hundreds of laws to enhance access to and financing for in-patient beds, cut red tape surrounding medication assisted treatment, and strengthen outreach and recovery coach programmes.

Advertisment

Why not utilise public monies for treatment?

Despite rising mortality rates, Experts agree that these public healthcare expenditures are essential to cure America's opioid and drug addiction problems.

Who'd argue?

It's scary to doubt an expert consensus on a fatal pandemic response.

Today's medicinal remedy for high-risk opioid usage with mortality risk doesn't involve a doctor or clinic visit. Use your phone. Suboxone, "subs," are ubiquitous, in infinite supply, and accessible to any street opiate addict who wishes to avoid the daily danger of death. Top medical officials have told us that's a widespread illegal usage of Suboxone.

JE
Advertisment
Chat with Dr. Medriva !